Related Experiment Video
Updated: Jun 26, 2026

08:17
Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
Published on: September 22, 2017
19.2K
On-axis full-field swept-source optical coherence tomography for murine retinal imaging
Optics Letters
|August 15, 2024
Summary
A novel full-field swept-source optical coherence tomography (FF-SS-OCT) system enables high-resolution in vivo imaging of the murine retina. This advanced OCT technology reveals detailed retinal structures and vascular plexuses for enhanced preclinical research.
Area of Science:
- Biomedical Optics
- Ophthalmology
- Preclinical Imaging
Background:
- Optical Coherence Tomography (OCT) is crucial for retinal imaging.
- Existing OCT systems face limitations in speed and resolution for in vivo murine studies.
- Need for advanced imaging techniques to visualize microscopic retinal features.
Purpose of the Study:
- To demonstrate a full-field swept-source OCT (FF-SS-OCT) system for in vivo murine retinal imaging.
- To achieve high-speed, high-resolution imaging of retinal microstructures.
- To provide a tool for detailed analysis of retinal layers and vascular networks.
Main Methods:
- Development of an on-axis FF-SS-OCT system using a Mach-Zehnder interferometer.
- Incorporation of a tunable laser source and a fast 2D-CMOS camera.
- Optimization of imaging interface, spatial sampling, and pupil stop for enhanced image quality and aberration reduction.
Main Results:
- Demonstration of FF-SS-OCT for in vivo murine retinal imaging at 150 Hz sweep rate.
- Achieved effective axial scan rate of 20 million A-scans/s and field of view of 820 × 410 µm.
- Obtained high-quality retinal B-scans and en face images revealing all major retinal layers and vascular plexuses.
Conclusions:
- The developed FF-SS-OCT system provides high-speed, high-resolution imaging of the murine retina.
- This technology is suitable for detailed visualization of retinal microanatomy and vasculature in preclinical research.
- FF-SS-OCT offers a valuable tool for advancing ophthalmological research and drug development.

